settlement
Cancer Genetics Settles Failed Merger Deal With NovellusDx; Receives $6M From Interpace
Cancer Genetics announced its planned merger with NovellusDx in September 2018, but scuttled the deal with the Israeli company a few months later.
10x Genomics to Pay $25M, Cross-License Patents to End BD Infringement Suit
10x will pay Becton Dickinson $25 million over four years and the firms have agreed to refrain from engaging in a legal battle on other fronts.
PacBio, Oxford Nanopore Settle Patent Dispute in Europe
Under the terms of the agreement, Oxford Nanopore Technologies will not sell its 2D sequencing products in the UK and in Germany for five years.
Biotheranostics Settles False Claims Allegations With DOJ for $2M
The DOJ alleged Biotheranosics promoted and performed its Breast Cancer Index test for patients who had not been in remission for five years and who had not been taking tamoxifen.
Alere Settles With SEC for $13M
The deal ends an investigation by the SEC into certain accounting practices by Alere's foreign subsidiaries. The company also consented to a cease-and-desist order.Â